Zobrazeno 1 - 6 of 6 pro vyhledávání: '"Marina Pittiglio"'
1
Retrospective analysis of anti-inflammatory therapies during the first wave of COVID-19 at a community hospital
Autor: Jesse B. Sullivan, Vishal Patel, Rajesh Mohan, Lydia Ayad, Satyendra P Singh, Yasmine Elbaga, Emad Gobran, Wajahat Khan, Nikunjkumar Patel, Payam Benson, Alexander Clark, Jose I. Iglesias, Marina Pittiglio, Andrew Vassallo, Kaliope Damalas
Publikováno v: World Journal of Critical Care Medicine
BACKGROUND Our understanding of the severe acute respiratory syndrome coronavirus 2 has evolved since the first reported cases in December 2019, and a greater emphasis has been placed on the hyper-inflammatory response in severely ill patients. The p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aea13878cab1e3f6877a290d4f5e0e9
http://europepmc.org/articles/PMC8462025
Zobrazit plný text záznamu
2
Real-world evaluation of the impact of two anti-SARS-CoV-2 monoclonal antibody regimens on COVID-19 hospitalizations in older adults
Autor: Kristine A. Sobolewski, Steven M. Smoke, Alison Brophy, Andrew V. Vassallo, Brandon Chen, Patrick Hilden, Rebecca Patterson, Marina Pittiglio, Karan Raja, Eric Handler, Christopher Freer
Publikováno v: Journal of medical virology. 94(6)
Evidence from clinical trials suggest anti-SARS-CoV-2 monoclonal antibodies (mABs) may reduce coronavirus disease 2019 (COVID-19)-related hospitalizations. The purpose of this study was to assess the real-world impact of mAB administration on COVID-1
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b71e3ecc84472bd388e83c500b7fcb63
https://pubmed.ncbi.nlm.nih.gov/35199356
Zobrazit plný text záznamu
5
309: Evaluation of the Efficacy of Tocilizumab in Critically Ill COVID-19 Patients
Autor: Kayla Riggs, Jesse B. Sullivan, Marina Pittiglio, Vishal Patel, Joseph E. Cavanaugh
Publikováno v: Critical Care Medicine. 49:141-141
INTRODUCTION: The COVID-19 outbreak has been declared a pandemic by the World Health Organization (WHO) There is an emergent need to identify effective treatment strategies Recent attention has been brought to tocilizumab, a recombinant monoclonal an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4a7ce6c95c24c1c2c662a5479492511f
https://doi.org/10.1097/01.ccm.0000727124.78530.08
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje